Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array)
Profilaggrin
- Product No.CMJ103Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typetissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length4h
- Detection Range0.0195-20ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.0065ng/mL.
- DownloadInstruction Manual
- UOM 48T96T
- FOB
US$ 588
US$ 840
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 89-99 | 94 |
| EDTA plasma(n=5) | 91-101 | 96 |
| heparin plasma(n=5) | 88-104 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 89-99% | 91-102% | 87-95% | 80-88% |
| EDTA plasma(n=5) | 91-98% | 94-102% | 96-105% | 78-104% |
| heparin plasma(n=5) | 78-95% | 92-101% | 88-95% | 96-103% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Journal of the Egyptian Women's Dermatologic Society | Filaggrin R501x and 2282del4 gene mutations and its tissue levels in patients with chronic plaque psoriasis LWW: 01000 |
| ?Inflammation & Allergy-Drug Targets | Neuromodulatory and Anti-Inflammatory Ingredient for Sensitive Skin: In Vitro Assessment Pubmed:24931812 |
| PLoS One | Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes Pubmed:26731545 |
| Journal of food biochemistry | In vitro anti-inflammatory and skin protective properties of extract comprising ceramides from de-oiled rice bran doi:10.1111 |
| European Journal of Pharmacology | Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. pubmed:28736282 |
| Journal of Dermatological Science | A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal … Pubmed:29752146 |
| Journal of Traditional and Complementary Medicine | In vitro anti-inflammatory and skin protective properties of Virgin coconut oil 10.1016:j.jtcme.2017.06.012 |
| Clinical and Molecular Allergy | Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and … |
| Intractable & Rare Diseases Research | Filaggrin, major basic protein and leukotriene B4: Biomarkers for adult patients of bronchial asthma, atopic dermatitis and allergic rhinitis Pubmed: 30560019 |
| Dermatology and Therapy | Epidermal and Dermal Hallmarks of Photoaging are Prevented by Treatment with Night Serum Containing Melatonin, Bakuchiol, and Ascorbyl … |
| 日本化粧品技術者会誌 | 糖化に起因する表皮機能低下に対するワイルドタイムエキスの防御効果 |
| J Dermatol | Filaggrin‐gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis 34322929 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPJ103Hu02 | Recombinant Filaggrin (FLG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPJ103Hu01 | Recombinant Filaggrin (FLG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPJ103Hu05 | Recombinant Filaggrin (FLG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPJ103Hu61 | Eukaryotic Filaggrin (FLG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPJ103Hu03 | Recombinant Filaggrin (FLG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| APJ103Hu61 | Active Filaggrin (FLG) | Cell culture; Activity Assays. |
| RPJ103Hu04 | Recombinant Filaggrin (FLG) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ103Hu01 | Polyclonal Antibody to Filaggrin (FLG) | WB |
| PAJ103Hu02 | Polyclonal Antibody to Filaggrin (FLG) | Testing in progress |
| LAJ103Hu71 | Biotin-Linked Polyclonal Antibody to Filaggrin (FLG) | WB; IHC; ICC. |
| LAJ103Hu83 | FITC-Linked Polyclonal Antibody to Filaggrin (FLG) | WB; IHC; ICC; IF. |
| LAJ103Hu81 | FITC-Linked Polyclonal Antibody to Filaggrin (FLG) | WB; IHC; ICC; IF. |
| MAJ103Hu21 | Monoclonal Antibody to Filaggrin (FLG) | Testing in progress |
| SEJ103Hu | ELISA Kit for Filaggrin (FLG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCJ103Hu | CLIA Kit for Filaggrin (FLG) | Chemiluminescent immunoassay for Antigen Detection. |
| LMJ103Hu | Multiplex Assay Kit for Filaggrin (FLG) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
| CMJ103Hu | Multiplex Assay Kit for Filaggrin (FLG) ,etc. by CBA (Cytometric Bead Array) | FLIA Kit for Antigen Detection. |

